ResearcherBayer (Germany)No recent work listed

Oliver von Ahsen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1906-9078; OpenAlex author ID A5087387263. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper

Papers 2

Isolation of circulating tumor cells from pancreatic cancer by automated filtration. Last author DOI 10.18632/oncotarget.21026 ↗
Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer. Last author DOI 10.1373/clinchem.2016.257469 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nora Brychta · 2 shared papers, 2016–2017 · strength 0.16
- Paper Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer. DOI 10.1373/clinchem.2016.257469 ↗
- Paper Isolation of circulating tumor cells from pancreatic cancer by automated filtration. DOI 10.18632/oncotarget.21026 ↗
Nikolas Hendrik Stoecklein · 1 shared paper, 2017 · strength 0.06
- Paper Isolation of circulating tumor cells from pancreatic cancer by automated filtration. DOI 10.18632/oncotarget.21026 ↗
Wolfram Trudo Knoefel · 1 shared paper, 2017 · strength 0.06
- Paper Isolation of circulating tumor cells from pancreatic cancer by automated filtration. DOI 10.18632/oncotarget.21026 ↗
Iréne Esposito · 1 shared paper, 2017 · strength 0.06
- Paper Isolation of circulating tumor cells from pancreatic cancer by automated filtration. DOI 10.18632/oncotarget.21026 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.